JP2020520987A5 - - Google Patents

Download PDF

Info

Publication number
JP2020520987A5
JP2020520987A5 JP2019565468A JP2019565468A JP2020520987A5 JP 2020520987 A5 JP2020520987 A5 JP 2020520987A5 JP 2019565468 A JP2019565468 A JP 2019565468A JP 2019565468 A JP2019565468 A JP 2019565468A JP 2020520987 A5 JP2020520987 A5 JP 2020520987A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
infection
lungs
gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019565468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020520987A (ja
JP7210476B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/033963 external-priority patent/WO2018217808A1/en
Publication of JP2020520987A publication Critical patent/JP2020520987A/ja
Publication of JP2020520987A5 publication Critical patent/JP2020520987A5/ja
Application granted granted Critical
Publication of JP7210476B2 publication Critical patent/JP7210476B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019565468A 2017-05-22 2018-05-22 リポ‐グリコペプチド可切断性誘導体及びその使用 Active JP7210476B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762509378P 2017-05-22 2017-05-22
US62/509,378 2017-05-22
US201762518280P 2017-06-12 2017-06-12
US62/518,280 2017-06-12
US201762560413P 2017-09-19 2017-09-19
US62/560,413 2017-09-19
PCT/US2018/033963 WO2018217808A1 (en) 2017-05-22 2018-05-22 Lipo-glycopeptide cleavable derivatives and uses thereof

Publications (3)

Publication Number Publication Date
JP2020520987A JP2020520987A (ja) 2020-07-16
JP2020520987A5 true JP2020520987A5 (cg-RX-API-DMAC7.html) 2021-07-26
JP7210476B2 JP7210476B2 (ja) 2023-01-23

Family

ID=64395938

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019565425A Expired - Fee Related JP7165146B2 (ja) 2017-05-22 2018-05-22 グリコペプチド誘導体化合物およびそれらの使用
JP2019565468A Active JP7210476B2 (ja) 2017-05-22 2018-05-22 リポ‐グリコペプチド可切断性誘導体及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019565425A Expired - Fee Related JP7165146B2 (ja) 2017-05-22 2018-05-22 グリコペプチド誘導体化合物およびそれらの使用

Country Status (10)

Country Link
US (3) US20200368312A1 (cg-RX-API-DMAC7.html)
EP (2) EP3634464A4 (cg-RX-API-DMAC7.html)
JP (2) JP7165146B2 (cg-RX-API-DMAC7.html)
KR (2) KR102661786B1 (cg-RX-API-DMAC7.html)
CN (2) CN110996984A (cg-RX-API-DMAC7.html)
AU (2) AU2018271873B2 (cg-RX-API-DMAC7.html)
BR (2) BR112019024549A2 (cg-RX-API-DMAC7.html)
GB (2) GB2577420B (cg-RX-API-DMAC7.html)
IL (2) IL270685B (cg-RX-API-DMAC7.html)
WO (2) WO2018217808A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
GB2577420B (en) 2017-05-22 2022-07-06 Insmed Inc Glycopeptide derivative compounds and uses thereof
NL2023883B1 (en) * 2019-09-24 2021-04-26 Univ Leiden Antibiotic compounds
US11793808B2 (en) 2021-02-22 2023-10-24 Mannkind Corp. Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
WO2023094994A1 (en) * 2021-11-24 2023-06-01 Cumberland Pharmaceuticals Inc Methods for the prevention or treatment of anthrax infection
CN121270649A (zh) * 2024-07-03 2026-01-06 烟台新药创制山东省实验室 一类万古霉素衍生物、其制备方法、药物组合物和用途

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639433A (en) 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
EP0273727A3 (en) * 1986-12-30 1990-01-17 Smithkline Beecham Corporation Glycosylated glycopeptides
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
PT101450B (pt) 1994-02-02 1999-11-30 Hovione Produtos Farmaceuticos Novo dispositivo para inalacao
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US6001336A (en) 1996-12-31 1999-12-14 Inhale Therapeutic Systems Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof
ATE248583T1 (de) 1997-09-29 2003-09-15 Nektar Therapeutics In dosierinhalatoren verwendbare, stabilisierte zubereitungen
WO1999016420A1 (en) 1997-09-29 1999-04-08 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in nebulizers
US6518242B1 (en) * 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
WO1999063929A2 (en) * 1998-06-08 1999-12-16 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
UA73924C2 (en) 1998-10-09 2005-10-17 Nektar Therapeutics Device for delivering active agent formulation to lungs of human patient
US6392012B1 (en) * 1998-12-23 2002-05-21 Advanced Medicine, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
PT1181069E (pt) 1999-05-28 2006-11-30 Nektar Therapeutics Dispositivo e método para a administração de uma dose calibrada de medicamento em aerosol
US6606992B1 (en) 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
WO2001057071A2 (en) 2000-02-04 2001-08-09 Advanced Medicine, Inc. Glycopeptide derivatives having antibiotic activity
AU2001238180B8 (en) 2000-02-11 2006-07-27 Eli Lilly And Company Selective N-acylation of A82846 glycopeptide analogs
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
TWI312785B (en) * 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
AU2003287605A1 (en) * 2002-11-12 2004-06-03 Enzon Pharmaceuticals, Inc. Polymeric prodrugs of vancomycin
WO2004110473A1 (en) 2003-05-27 2004-12-23 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
TWI342312B (en) * 2003-10-22 2011-05-21 Theravance Inc Hydrochloride salts of a glycopeptide phosphonate derivative
US20070185015A1 (en) * 2005-02-28 2007-08-09 Chiron Corporation and North China Pharmaceutical Corporation Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
KR20100060004A (ko) * 2007-09-25 2010-06-04 노파르티스 아게 에어로졸화된 반코마이신과 같은 의약에 의한 폐 질병의 치료
MX2010004389A (es) * 2007-10-23 2010-05-20 Transave Inc Formulaciones de vancomicina liposomales.
EP2238102A4 (en) * 2007-12-26 2011-03-09 Lead Therapeutics Inc NEW HALF-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS
WO2010048340A2 (en) * 2008-10-24 2010-04-29 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
AU2010229721A1 (en) * 2009-03-26 2011-10-06 Pulmatrix, Inc. Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis
PT2424559T (pt) * 2009-04-28 2024-04-30 Melinta Therapeutics Llc Métodos de tratamento de infeções bacterianas utilizando oritavancina
SG195038A1 (en) * 2011-05-19 2013-12-30 Savara Inc Dry powder vancomycin compositions and associated methods
US9572774B2 (en) * 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
JP6254525B2 (ja) 2011-08-05 2017-12-27 ザ スクリプス リサーチ インスティテュート バンコマイシン耐性菌株に対して有効なグリコペプチド系抗生物質類似体
PL2852391T3 (pl) * 2012-05-21 2022-04-11 Insmed Incorporated Układy do leczenia infekcji płuc
CA2891487A1 (en) * 2012-11-29 2014-06-05 Insmed Incorporated Stabilized vancomycin formulations
GB201402267D0 (en) * 2014-02-10 2014-03-26 Cambridge Entpr Ltd Antibacterial agents
CN105085636B (zh) * 2014-05-19 2020-05-01 中国医学科学院药物研究所 一类万古霉素衍生物、其制备方法及其在抗菌方面的应用
WO2016007855A1 (en) 2014-07-10 2016-01-14 The Scripps Research Institute N- (hydrophobe-substituted) vancosaminyl [ψ[c(=nh) nh] tpg4] vancomycin and [ψ[ch2nh]tpg4] vancomycin
CN107325159A (zh) 2016-04-29 2017-11-07 中国科学院上海药物研究所 一类万古霉素衍生物、其制备方法、药物组合物和用途
WO2018008197A1 (ja) 2016-07-07 2018-01-11 日東電工株式会社 反射層および蛍光体層付光半導体素子
CA3042039C (en) 2016-10-31 2023-09-26 The Scripps Research Institute Peripheral modifications on pocket-redesigned vancomycin analogs synergistically improve antimicrobial potency and durability
GB2577420B (en) 2017-05-22 2022-07-06 Insmed Inc Glycopeptide derivative compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2016513688A5 (cg-RX-API-DMAC7.html)
RU2015138796A (ru) Способы и составы для лечения респираторных заболеваний
RU2015129062A (ru) Соединения 3, 5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида
JP2005523922A5 (cg-RX-API-DMAC7.html)
JP2009538327A5 (cg-RX-API-DMAC7.html)
JP2006182786A5 (cg-RX-API-DMAC7.html)
JP2018021051A5 (cg-RX-API-DMAC7.html)
JP2011520911A5 (cg-RX-API-DMAC7.html)
HRP20151346T1 (hr) 3,5-diamino-6-klor-n-(n-(4-(4-(2-(heksil(2,3,4,5,6-pentahidroksiheksil)amino)etoksi)fenil)butil)karbamimidoil)pirazin-2-karboksamid
JP2010508365A5 (cg-RX-API-DMAC7.html)
JP2015521617A5 (cg-RX-API-DMAC7.html)
JP2010530372A5 (cg-RX-API-DMAC7.html)
JP2011173929A (ja) 呼吸器官の細菌性疾患の処置
JP2013528640A5 (cg-RX-API-DMAC7.html)
JP2020512337A5 (cg-RX-API-DMAC7.html)
JP2013542992A5 (cg-RX-API-DMAC7.html)
JP2023109937A5 (cg-RX-API-DMAC7.html)
JP2020520986A5 (cg-RX-API-DMAC7.html)
JP2017529398A5 (cg-RX-API-DMAC7.html)
Berendt et al. Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanamycin
JP2026021451A5 (cg-RX-API-DMAC7.html)
JP2025118775A5 (cg-RX-API-DMAC7.html)
JP2010507576A5 (cg-RX-API-DMAC7.html)
JP2023540259A5 (cg-RX-API-DMAC7.html)
JP2010500284A5 (cg-RX-API-DMAC7.html)